लोड हो रहा है...
Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patients
BACKGROUND: Cetuximab and bevacizumab reportedly improve the survival of patients with metastatic colorectal cancer (mCRC), but their most effective sequence of administration is unknown. The aim of this study was to compare the survival of patients with mCRC treated with cetuximab after bevacizumab...
में बचाया:
| में प्रकाशित: | Onco Targets Ther |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Dove Medical Press
2015
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4648607/ https://ncbi.nlm.nih.gov/pubmed/26648737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S89241 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|